LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 25 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $56,576,000 | +32.9% | 15,472,000 | 0.0% | 0.02% | +26.7% |
| Q2 2018 | $42,563,000 | -15.3% | 15,472,000 | -32.6% | 0.02% | -16.7% |
| Q1 2018 | $50,269,000 | +42.9% | 22,972,000 | +19.0% | 0.02% | +50.0% |
| Q4 2017 | $35,184,000 | -0.1% | 19,312,000 | 0.0% | 0.01% | -14.3% |
| Q3 2017 | $35,232,000 | +10.2% | 19,312,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $31,961,000 | +31.5% | 19,312,000 | +18.4% | 0.01% | +16.7% |
| Q1 2017 | $24,305,000 | +3.2% | 16,312,000 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $23,550,000 | -20.6% | 16,312,000 | -19.7% | 0.01% | -14.3% |
| Q3 2016 | $29,643,000 | – | 20,312,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|